Literature DB >> 10704429

Molecular genetics of peroxisomal disorders.

H W Moser1.   

Abstract

Twenty five human peroxisomal disorders have been defined at this time. They are subdivided into two major categories: 1) the disorders of peroxisome biogenesis, in which the organelle fails to form normally, and there are defects that involve multiple peroxisomal functions; and 2) disorders that affect single peroxisomal enzymes. During the last five years the molecular defects have been identified in nearly all. These recent advances have several important implications. They have facilitated diagnosis of affected patients. The improved capacity to provide prenatal diagnosis and heterozygote identification has been of great value for genetic counseling and disease prevention. Study of genotype-phenotype correlations has led to a new and more rational classification system. The identification of the molecular defects and the development of animal models have increased understanding of pathogenetic mechanisms, and have led to novel therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704429     DOI: 10.2741/moser

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  12 in total

1.  Learning cell biology as a team: a project-based approach to upper-division cell biology.

Authors:  Robin Wright; James Boggs
Journal:  Cell Biol Educ       Date:  2002

2.  Impaired neurotransmission in ether lipid-deficient nerve terminals.

Authors:  Alexander Brodde; Andre Teigler; Britta Brugger; Wolf D Lehmann; Felix Wieland; Johannes Berger; Wilhelm W Just
Journal:  Hum Mol Genet       Date:  2012-03-08       Impact factor: 6.150

3.  Manganese treatment modulates the expression of peroxisome proliferator-activated receptors in astrocytoma and neuroblastoma cells.

Authors:  Alfred Orina Isaac; Ivana Kawikova; Alfred L M Bothwell; Christopher K Daniels; James C K Lai
Journal:  Neurochem Res       Date:  2006-10-20       Impact factor: 3.996

4.  Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1.

Authors:  E Rajcan-Separovic; C Harvard; X Liu; B McGillivray; J G Hall; Y Qiao; J Hurlburt; J Hildebrand; E C R Mickelson; J J A Holden; M E S Lewis
Journal:  J Med Genet       Date:  2006-09-08       Impact factor: 6.318

5.  Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse).

Authors:  E Baumgart; I Vanhorebeek; M Grabenbauer; M Borgers; P E Declercq; H D Fahimi; M Baes
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder.

Authors:  Jukka Kallijärvi; Kristiina Avela; Marita Lipsanen-Nyman; Ismo Ulmanen; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2002-04-05       Impact factor: 11.025

7.  Comparative analysis of gene-expression patterns in human and African great ape cultured fibroblasts.

Authors:  Mazen W Karaman; Marlys L Houck; Leona G Chemnick; Shailender Nagpal; Daniel Chawannakul; Dominick Sudano; Brian L Pike; Vincent V Ho; Oliver A Ryder; Joseph G Hacia
Journal:  Genome Res       Date:  2003-07       Impact factor: 9.043

8.  Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum.

Authors:  Andre Teigler; Dorde Komljenovic; Andreas Draguhn; Karin Gorgas; Wilhelm W Just
Journal:  Hum Mol Genet       Date:  2009-03-08       Impact factor: 6.150

9.  Ether-linked diglycerides inhibit vascular smooth muscle cell growth via decreased MAPK and PI3K/Akt signaling.

Authors:  Kristy L Houck; Todd E Fox; Lakshman Sandirasegarane; Mark Kester
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-22       Impact factor: 4.733

10.  PTS1 peroxisomal import pathway plays shared and distinct roles to PTS2 pathway in development and pathogenicity of Magnaporthe oryzae.

Authors:  Jiaoyu Wang; Zhen Zhang; Yanli Wang; Ling Li; Rongyao Chai; Xueqin Mao; Hua Jiang; Haiping Qiu; Xinfa Du; Fucheng Lin; Guochang Sun
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.